BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine

  June 30, 2025

   · 

  5 min read
• Press Releases

  PreveCeutical Welcomes Dr. Francis Tavares, PhD. As Chief Technology Officer

  June 30, 2025

   · 

  7 min read
• Press Releases

  Verastem Oncology Announces Nature Medicine Publication of the Results from the First-in-Human Phase 1 FRAME Study of Avutometinib in Combination with Defactinib in Solid Tumors, including Low-Grade Serious Ovarian Cancer

  June 30, 2025

   · 

  14 min read
• Press Releases

  Protagonist Announces Nomination of PN-477, an Oral and Injectable GLP-1R, GIPR, and GCGR Triple Agonist Peptide Development Candidate for Obesity

  June 30, 2025

   · 

  6 min read
• Press Releases

  Iksuda Therapeutics Receives FDA IND Clearance for IKS014

  June 30, 2025

   · 

  3 min read
• Press Releases

  Neurogene Announces Registrational Trial Design for Embolden™ Study of NGN-401 Gene Therapy for Rett Syndrome

  June 30, 2025

   · 

  11 min read
• Press Releases

  Mineralys Therapeutics Announces Journal of the American Medical Association (JAMA) Publication of Pivotal Phase 3 Launch-HTN Trial for Lorundrostat

  June 30, 2025

   · 

  9 min read
• Press Releases

  Gain Therapeutics Announces Completion of Target Enrollment in Phase 1b Clinical Study Evaluating GT-02287 in People With Parkinson’s Disease With or Without a GBA1 Mutation

  June 30, 2025

   · 

  7 min read
• Press Releases

  Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-01435, a Long-Acting Corticotropin-Releasing Factor Type 1 Receptor Antagonist

  June 30, 2025

   · 

  4 min read
• Press Releases

  AdipoPharma Recognized at American Diabetes Association 85th Annual Meeting for PATAS, Its First-in-Class Whole-Body Insulin-Sensitizing Compound

  June 30, 2025

   · 

  2 min read